Showing results (371-380 of 769) with videos related to
Sort By:
Pageof 77
South Asian Journal of Cancer|November 16, 2018
Expression of p16INK4a and human papillomavirus 16 with associated risk factors in cervical premalignant and malignant lesionsAbha Pandey, Smita Chandra, Ruchira Nautiyal, et al.South Asian Journal of Cancer|November 16, 2018
Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemiaRachana Chennamaneni, Sadashivudu Gundeti, Meher Lakshmi Konatam, et al.South Asian Journal of Cancer|November 16, 2018
Clinical and endoscopic response to high dose rate endobronchial brachytherapy in malignant lung tumors: A single centre experienceSneha Dhillon, Saurabh Bansal, Girish Sindhwani, et al.South Asian Journal of Cancer|September 7, 2019
A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinomaR Nanda, Aradhana Katke, N Suneetha, et al.South Asian Journal of Cancer|September 7, 2019
Langerhans cell histiocytosis: An enigmatic diseaseAnubha Jain, Sushil Kumar, Priyanka Aggarwal, et al.South Asian Journal of Cancer|September 7, 2019
Mutation profile in Indian primary myelofibrosis patients and its clinical implicationsVinod R Patil, S Chandrakala, Shruti Mantri, et al.South Asian Journal of Cancer|January 5, 2022
Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in IndiaPurvish M Parikh, Gouri Shankar Bhattacharyya, Ghanshyam Biswas, et al.South Asian Journal of Cancer|April 18, 2017
Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapySenthil Rajappa, Dinesh Chandra Doval, Jaydip Biswas, et al.South Asian Journal of Cancer|September 27, 2021
Real-World Experience in Toxicity with Bevacizumab in Indian Cancer PatientsPratik P Patil, Ranga R Rangaraju, Waseem Abbas, et al.South Asian Journal of Cancer|May 3, 2021
Frequency and Prognosis of Epidermal Growth Factor Receptor Variant III Mutations in Glioblastoma Multiforme among Indian Patients: A Single-Institution StudyWesley Mannirathil Jose, Vinayak Munirathnam, V Narendranath, et al.Pageof 77